Seeing Is Believing
BPMC is currently covered by 12 analysts with an average price target of $149.42. This is a potential upside of $19.96 (15.42%) from yesterday's end of day stock price of $129.46.
Blueprint Medicines Corp's activity chart (see below) currently has 358 price targets and 271 ratings on display. The stock rating distribution of BPMC is 32.35% HOLD and 67.65% BUY.
Analysts average stock forecasts to be materialized ratio is 84.65% with an average time for these price targets to be met of 266.28 days.
Highest price target for BPMC is $135, Lowest price target is $119, average price target is $129.33.
Most recent stock forecast was given by DEREK ARCHILA from WELLS FARGO on 16-Jun-2025. First documented stock forecast 25-May-2015.
Currently out of the existing stock ratings of BPMC, 11 are a HOLD (32.35%), 23 are a BUY (67.65%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$129
$-0.46 (-0.36%)
$151
3 months 23 days ago
(16-Jun-2025)
10/11 (90.91%)
$0.77 (0.60%)
110
Hold
$129
$-0.46 (-0.36%)
$102
4 months 5 days ago
(04-Jun-2025)
3/3 (100%)
$1.1 (0.86%)
27
Hold
$129
$-0.46 (-0.36%)
$76
4 months 6 days ago
(03-Jun-2025)
11/13 (84.62%)
$0.9 (0.70%)
229
Hold
$125
4 months 7 days ago
(02-Jun-2025)
16/18 (88.89%)
$35.25 (39.28%)
292
Hold
$129
$-0.46 (-0.36%)
$130
4 months 8 days ago
(01-Jun-2025)
3/4 (75%)
$1.21 (0.95%)
132
What is BPMC (Blueprint Medicines Corp) average time for price targets to be met?
Which analyst has the current highest performing score on BPMC (Blueprint Medicines Corp) with a proven track record?
Which analyst has the most public recommendations on BPMC (Blueprint Medicines Corp)?
Which analyst is the currently most bullish on BPMC (Blueprint Medicines Corp)?
Which analyst is the currently most reserved on BPMC (Blueprint Medicines Corp)?